{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T08:48:40Z","timestamp":1777798120072,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.3816\/clm.2009.n.036","type":"journal-article","created":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T01:09:38Z","timestamp":1241140178000},"page":"151-153","source":"Crossref","is-referenced-by-count":38,"title":["Varicella-Zoster Virus Prophylaxis with Low-Dose Acyclovir in Patients with Multiple Myeloma Treated with Bortezomib"],"prefix":"10.3816","volume":"9","author":[{"given":"Ludek","family":"Pour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenek","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Buresova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Krejci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Krivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viera","family":"Sandecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Zahradova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Buchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Vorlicek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Hajek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2009.n.036_bib1","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma","volume":"352","author":"Richardson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2009.n.036_bib2","first-page":"1498","article-title":"Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study","volume":"91","author":"Harousseau","year":"2006","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2009.n.036_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2141.2005.05540.x","article-title":"Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma","volume":"129","author":"Jagannath","year":"2005","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2009.n.036_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3816\/CLM.2008.n.004","article-title":"Multiple myeloma presenting with advanced renal failure: a case report and new treatment options","volume":"8","author":"Gladney","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.3816\/CLM.2009.n.036_bib5","series-title":"Multiple Myeloma and Other Monoclonal Gammapathies","first-page":"325","author":"Adam","year":"1999"},{"key":"10.3816\/CLM.2009.n.036_bib6","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1200\/JCO.2006.10.5460","article-title":"Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression","volume":"25","author":"Orlowski","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.036_bib7","first-page":"636","article-title":"Bortezomib (Velcade) in relapsed\/refractory multiple myeloma\u2013the first experience in the Czech Republic. [in Czech]","volume":"144","author":"Spicka","year":"2005","journal-title":"Cas Lek Cesk"},{"key":"10.3816\/CLM.2009.n.036_bib8","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1200\/JCO.2007.14.9641","article-title":"Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study","volume":"26","author":"Chanan-Khan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.n.036_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0609.2007.00930.x","article-title":"Monotherapy with low-dose thalidomide for relapsed or refractory multiple myeloma: better response rate with earlier treatment","volume":"79","author":"Maisnar","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2009.n.036_bib10","first-page":"345","article-title":"Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma","volume":"55","author":"Zemanova","year":"2008","journal-title":"Neoplasma"},{"key":"10.3816\/CLM.2009.n.036_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2141.2007.06656.x","article-title":"Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma","volume":"138","author":"Kropff","year":"2007","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2009.n.036_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.20838","article-title":"The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients","volume":"82","author":"Tong","year":"2007","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2009.n.036_bib13","first-page":"31a","article-title":"MMY-3002: A phase 3 study comparing bortezomib-melphalan-prednisone (VMP) with melphalan-prednisone (MP) in newly diagnosed multiple myeloma","volume":"110","author":"San Miguel","year":"2007","journal-title":"Blood"},{"issue":"suppl 2","key":"10.3816\/CLM.2009.n.036_bib14","article-title":"Management of toxicities from novel agents","volume":"92","author":"Hussein","year":"2007","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2009.n.036_bib15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/bmj.39206.571042.AE","article-title":"Herpes zoster","volume":"334","author":"Wareham","year":"2007","journal-title":"BMJ"},{"key":"10.3816\/CLM.2009.n.036_bib16","doi-asserted-by":"crossref","first-page":"1054a","DOI":"10.1182\/blood.V110.11.3603.3603","article-title":"Recovery of renal impairment by bortezomib-doxorubicin-dexamethasone (BDD) in multiple myeloma (MM) patients with acute renal failure. Results from an ongoing phase II study","volume":"110","author":"Ludwig","year":"2007","journal-title":"Blood"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011701871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011701871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T20:55:30Z","timestamp":1589748930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011701871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1557919011701871"],"URL":"https:\/\/doi.org\/10.3816\/clm.2009.n.036","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}